Literature DB >> 16469706

Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.

Ping Zhu1, Sung Hee Baek, Eliot M Bourk, Kenneth A Ohgi, Ivan Garcia-Bassets, Hideki Sanjo, Shizuo Akira, Paul F Kotol, Christopher K Glass, Michael G Rosenfeld, David W Rose.   

Abstract

Defining the precise molecular strategies that coordinate patterns of transcriptional responses to specific signals is central for understanding normal development and homeostasis as well as the pathogenesis of hormone-dependent cancers. Here we report specific prostate cancer cell/macrophage interactions that mediate a switch in function of selective androgen receptor antagonists/modulators (SARMs) from repression to activation in vivo. This is based on an evolutionarily conserved receptor N-terminal L/HX7LL motif, selectively present in sex steroid receptors, that causes recruitment of TAB2 as a component of an N-CoR corepressor complex. TAB2 acts as a sensor for inflammatory signals by serving as a molecular beacon for recruitment of MEKK1, which in turn mediates dismissal of the N-CoR/HDAC complex and permits derepression of androgen and estrogen receptor target genes. Surprisingly, this conserved sensor strategy may have arisen to mediate reversal of sex steroid-dependent repression of a limited cohort of target genes in response to inflammatory signals, linking inflammatory and nuclear receptor ligand responses to essential reproductive functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469706     DOI: 10.1016/j.cell.2005.12.032

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  122 in total

Review 1.  Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.

Authors:  Thomas Schmidt; Isabel Ben-Batalla; Alexander Schultze; Sonja Loges
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

Review 2.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

Review 3.  Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers.

Authors:  Sarah C Baumgarten; Jonna Frasor
Journal:  Mol Endocrinol       Date:  2012-02-02

4.  Polyubiquitination of transforming growth factor β (TGFβ)-associated kinase 1 mediates nuclear factor-κB activation in response to different inflammatory stimuli.

Authors:  Anahita Hamidi; Verena von Bulow; Rosita Hamidi; Nicolas Winssinger; Sofia Barluenga; Carl-Henrik Heldin; Marene Landström
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

5.  Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma.

Authors:  Serena Ghisletti; Wendy Huang; Sumito Ogawa; Gabriel Pascual; Mu-En Lin; Timothy M Willson; Michael G Rosenfeld; Christopher K Glass
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

6.  Positive correlation between PEDF expression levels and macrophage density in the human prostate.

Authors:  Thomas Nelius; Christina Samathanam; Dalia Martinez-Marin; Natalie Gaines; Jessica Stevens; Johnny Hickson; Werner de Riese; Stéphanie Filleur
Journal:  Prostate       Date:  2012-10-04       Impact factor: 4.104

7.  Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model.

Authors:  Sofia Halin; Stina Häggström Rudolfsson; Nico Van Rooijen; Anders Bergh
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

8.  Adoptive T-Cell Therapy for Solid Tumors.

Authors:  Oladapo Yeku; Xinghuo Li; Renier J Brentjens
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

9.  Epidermal growth factor (EGF)-enhanced vascular cell adhesion molecule-1 (VCAM-1) expression promotes macrophage and glioblastoma cell interaction and tumor cell invasion.

Authors:  Yanhua Zheng; Weiwei Yang; Kenneth Aldape; Jie He; Zhimin Lu
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

10.  Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor.

Authors:  Myles C Hodgson; Howard C Shen; Anthony N Hollenberg; Steven P Balk
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.